MedTrace Logo

The Norwegian Stroke in the Young Study II

NCT02762396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-05-24

No results posted yet for this study

Summary

NOR-SYS II is designed for finding the cause of acute ischemic stroke lesions in Young adults, age 15 to 49 years. Risk factors, arterial wall changes by intima-media thickness and plaques and consequences of stroke are examined by standardized diagnostics.

Conditions

  • Ischemic Stroke at a Young Age

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Ulrike Waje-Andreassen, MD, PhD · Haukeland University Hospital

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2021-02-28
Completion
2022-02-28

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02762396 on ClinicalTrials.gov